Has Dronabinol (Synthetic THC) Shown Efficacy for Anorexia?
Dronabinol, a pharmaceutical form of synthetic THC, has been studied as a possible treatment for eating disorders. Research into dronabinol for anorexia suggests it may improve appetite and support modest weight gain, though results remain mixed.
For patients with anorexia, such findings highlight the potential of cannabinoid-based medicines as part of broader care strategies.
What The Research Shows About Dronabinol
Clinical trials provide some insights into the therapeutic value of dronabinol for eating disorders.
Synthetic THC
As a form of synthetic THC, dronabinol mimics the appetite-stimulating effects of natural cannabis. Patients in some studies reported increased food intake and reduced meal-related anxiety.
Clinical Evidence
The clinical evidence to date suggests dronabinol may offer short-term benefits, particularly in improving appetite. However, trials often involve small groups, making it difficult to draw firm conclusions.
Appetite Stimulation
One of the clearest findings is appetite stimulation, with some patients experiencing improvements in weight restoration. Still, side effects such as dizziness and fatigue remain considerations.
In summary, while dronabinol for anorexia studies shows promise, more robust research is needed to determine its long-term safety and effectiveness. It is best viewed as a potential adjunct rather than a primary therapy.
Visit providers like LeafEase for expert insights into the role of synthetic THC and other cannabinoids in anorexia treatment.
For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Anorexia.
